Abstract
Shortly after the introduction of streptomycin and dihydrostreptomycin in the treatment of tuberculosis, irreversible perceptive hearing losses were noted as a side effect. Although hearing loss became less of a problem when reduced dosage schedules were adopted, the more widespread use of these drugs, often in combinations with other antibiotics, in nontuberculous disease has caused an increase in hearing loss in the last few years. Neomycin and kanamycin share this ototoxic property. Widespread use of these drugs is resulting in loss of hearing in a significant number of cases.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GLORIG A. The effect of dihydrostreptomycin hydrochloride and sulfate on the auditory mechanism. Ann Otol Rhinol Laryngol. 1951 Jun;60(2):327–335. doi: 10.1177/000348945106000204. [DOI] [PubMed] [Google Scholar]
- GLORIG A. The relation of streptomycin and dihydrostreptomycin to hearing and the vestibular apparatus. J Speech Disord. 1950 Jun;15(2):124–128. doi: 10.1044/jshd.1502.124. [DOI] [PubMed] [Google Scholar]
- GREENWOOD G. J. Neomycin ototoxicity; report of a case. AMA Arch Otolaryngol. 1959 Apr;69(4):390–397. doi: 10.1001/archotol.1959.00730030400002. [DOI] [PubMed] [Google Scholar]
- HAWKINS J. E., Jr The ototoxicity of kanamycin. Ann Otol Rhinol Laryngol. 1959 Sep;68:698–715. doi: 10.1177/000348945906800307. [DOI] [PubMed] [Google Scholar]
- SHAMBAUGH G. E., Jr, DERLACKI E. L., HARRISON W. H., HOUSE H., HOUSE W., HILDYARD V., SCHUKNECHT H., SHEA J. J. Dihydrostreptomycin deafness. J Am Med Assoc. 1959 Aug 1;170(14):1657–1660. doi: 10.1001/jama.1959.03010140037010. [DOI] [PubMed] [Google Scholar]